Owlytics’ MS Smartwatch Goes Through First Validation Stage & Tools to Manage MS Symptoms

Jan 19, 2022, 12:00 AM

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Owlytics’ provided scientific evidence that the smartwatch may be used as a measure of response to a treatment in a clinical trial.
Plus, reads “Curing Headaches, Pain, and Stress, One Gizmo at a Time”, a column by Jamie Hughes.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/